We evaluated the role of [18F]FDG PET/CT in tumor response assessment and prognosis of Primary Extranodal Lymphoma (PEL) patients.

2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography in primary extranodal lymphomas: treatment response evaluation and prognosis / Salvatore, Barbara; Fonti, Rosa; De Renzo, Amalia; Pellegrino, Sara; Ferrara, Ida L; Mainolfi, Ciro G; Marano, Luana; Selleri, Carmine; Pane, Fabrizio; Del Vecchio, Silvana; Pace, Leonardo. - In: THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. - ISSN 1827-1936. - 64:2(2020), pp. 219-225. [10.23736/S1824-4785.18.03043-1]

2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography in primary extranodal lymphomas: treatment response evaluation and prognosis

Fonti, Rosa;De Renzo, Amalia;Pellegrino, Sara;Ferrara, Ida L;Mainolfi, Ciro G;Marano, Luana;Selleri, Carmine;Pane, Fabrizio;Del Vecchio, Silvana;Pace, Leonardo
2020

Abstract

We evaluated the role of [18F]FDG PET/CT in tumor response assessment and prognosis of Primary Extranodal Lymphoma (PEL) patients.
2020
2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography in primary extranodal lymphomas: treatment response evaluation and prognosis / Salvatore, Barbara; Fonti, Rosa; De Renzo, Amalia; Pellegrino, Sara; Ferrara, Ida L; Mainolfi, Ciro G; Marano, Luana; Selleri, Carmine; Pane, Fabrizio; Del Vecchio, Silvana; Pace, Leonardo. - In: THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. - ISSN 1827-1936. - 64:2(2020), pp. 219-225. [10.23736/S1824-4785.18.03043-1]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/721800
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact